Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 20, 2022

SELL
$31.71 - $43.0 $3,488 - $4,730
-110 Closed
0 $0
Q2 2021

Aug 05, 2021

BUY
$34.54 - $47.25 $3,799 - $5,197
110 New
110 $4,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Mc Carthy Asset Management, Inc. Portfolio

Follow Mc Carthy Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mc Carthy Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mc Carthy Asset Management, Inc. with notifications on news.